Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (11-20 of 214) with videos related to

Pageof 22
Sort By:
Obesity (Silver Spring, Md.)|January 17, 2008
Effect of obesity on high-density lipoprotein metabolismShirya Rashid, Jacques Genest
Cholesterol|June 20, 2013
HDL, Atherosclerosis, and Emerging TherapiesAnouar Hafiane, Jacques Genest
Revue Medicale Suisse|March 1, 2018
[Screening for atherosclerosis to prevent cardiovascular risk : a pro-contra debate]David Nanchen, Jacques Genest
Current Atherosclerosis Reports|November 6, 2017
Novel Approaches for HDL-Directed TherapiesJacques Genest, Hong Y Choi
Current Opinion in Endocrinology, Diabetes, and Obesity|February 19, 2014
Treatment options for low high-density lipoproteinsAnouar Hafiane, Samantha Kellett, Jacques Genest
Current Opinion in Lipidology|May 9, 2006
New insights into the biogenesis of human high-density lipoproteinsLarbi Krimbou, Michel Marcil, Jacques Genest
Clinical Chemistry|September 25, 2014
Proprotein convertase subtilisin/kexin type 9 (PCSK9): lessons learned from patients with hypercholesterolemiaZuhier Awan, Alexis Baass, Jacques Genest
The American Journal of Cardiology|March 31, 2004
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitusJacques Genest, Jiri Frohlich, George Steiner
Current Opinion in Lipidology|January 23, 2018
Familial hypercholesterolemia: experience from the French-Canadian populationMartine Paquette, Jacques Genest, Alexis Baass
Frontiers in Pharmacology|June 7, 2021
Identification of Docetaxel as a Potential Drug to Promote HDL BiogenesisHong Y Choi, Isabelle Ruel, Jacques Genest
Pageof 22

Showing results (11-20 of 214) with videos related to

Sort By:
Pageof 22
Obesity (Silver Spring, Md.)|January 17, 2008
Effect of obesity on high-density lipoprotein metabolismShirya Rashid, Jacques Genest
Cholesterol|June 20, 2013
HDL, Atherosclerosis, and Emerging TherapiesAnouar Hafiane, Jacques Genest
Revue Medicale Suisse|March 1, 2018
[Screening for atherosclerosis to prevent cardiovascular risk : a pro-contra debate]David Nanchen, Jacques Genest
Current Atherosclerosis Reports|November 6, 2017
Novel Approaches for HDL-Directed TherapiesJacques Genest, Hong Y Choi
Current Opinion in Endocrinology, Diabetes, and Obesity|February 19, 2014
Treatment options for low high-density lipoproteinsAnouar Hafiane, Samantha Kellett, Jacques Genest
Current Opinion in Lipidology|May 9, 2006
New insights into the biogenesis of human high-density lipoproteinsLarbi Krimbou, Michel Marcil, Jacques Genest
Clinical Chemistry|September 25, 2014
Proprotein convertase subtilisin/kexin type 9 (PCSK9): lessons learned from patients with hypercholesterolemiaZuhier Awan, Alexis Baass, Jacques Genest
The American Journal of Cardiology|March 31, 2004
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitusJacques Genest, Jiri Frohlich, George Steiner
Current Opinion in Lipidology|January 23, 2018
Familial hypercholesterolemia: experience from the French-Canadian populationMartine Paquette, Jacques Genest, Alexis Baass
Frontiers in Pharmacology|June 7, 2021
Identification of Docetaxel as a Potential Drug to Promote HDL BiogenesisHong Y Choi, Isabelle Ruel, Jacques Genest
Pageof 22